Ona Therapeutics: Funding, Investors & Team (Sep 2026)
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Ona Therapeutics has raised $128M across 3 funding rounds on record, the most recent a Series B of $86.6M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ona Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Ona Therapeutics Funding Rounds
Ona Therapeutics raised $30.0M in an undisclosed round announced in Jun 2020.
5.3 years later, an undisclosed round of $11.6M was announced in Oct 2025.
8 months later, a Series B of $86.6M was announced in Jun 2026.
Ona Therapeutics Founders and Leadership Team
Contact details for the Ona Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Ona Therapeutics Funding Compared to Other Biotechnology Startups
Ona Therapeutics' latest round of $86.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ona Therapeutics in Biotechnology and Barcelona
Companies Similar to Ona Therapeutics
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of…
Ona Therapeutics Funding FAQs
What does Ona Therapeutics do?
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
How much funding has Ona Therapeutics raised?
Ona Therapeutics has raised $128M across 3 rounds on record. The most recent is a Series B of $86.6M announced in Jun 2026.
When did Ona Therapeutics last raise funding?
Ona Therapeutics' most recent funding round on record is a Series B of $86.6M, announced in Jun 2026.
Who founded Ona Therapeutics?
FundedIQ lists Salvador Aznar Benitah (Founder) at Ona Therapeutics.
Who is the CEO of Ona Therapeutics?
Valerie Vanhooren is listed as CEO at Ona Therapeutics.
Where is Ona Therapeutics headquartered?
Ona Therapeutics is based in Barcelona, Catalonia, Spain.
How many employees does Ona Therapeutics have?
Ona Therapeutics is in the 11-50 employee band.
How does Ona Therapeutics' funding compare to other Biotechnology startups?
Ona Therapeutics' latest round of $86.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Ona Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ona Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.